Skip to Main Content
Table 1—

Baseline clinical characteristics of the two treatment groups

CSIIMDIP
n 16 16 — 
Age (years) 12.5 ± 3.2 13 ± 2.8 0.637 
Sex (F/M) 10/6 8/8 0.722 
Race (white/Hispanic/black) 11/3/2 13/2/1 0.705 
Duration of diabetes (years) 6.8 ± 3.8 5.6 ± 4.0 0.391 
Initial treatment (no. of injections) 12 b.i.d./4 MDI 14 b.i.d./2 MDI 0.654 
TDD prestudy enrollment (units/kg) 1.4 ± 0.5 1.1 ± 0.3 0.087 
CSIIMDIP
n 16 16 — 
Age (years) 12.5 ± 3.2 13 ± 2.8 0.637 
Sex (F/M) 10/6 8/8 0.722 
Race (white/Hispanic/black) 11/3/2 13/2/1 0.705 
Duration of diabetes (years) 6.8 ± 3.8 5.6 ± 4.0 0.391 
Initial treatment (no. of injections) 12 b.i.d./4 MDI 14 b.i.d./2 MDI 0.654 
TDD prestudy enrollment (units/kg) 1.4 ± 0.5 1.1 ± 0.3 0.087 

Data are means ± SD.

Close Modal

or Create an Account

Close Modal
Close Modal